Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
To evaluate the efficacy and safety of the combination of Gentuximab Injection and Paclitaxel Injection in patients with advanced gastric or gastroesophageal junction adenocarcinoma after first-line treatment failure compared with Placebo and Paclitaxel Injection.
Epistemonikos ID: fc2e62e35396ee04ec17f5b4a0cad69fd4be5bb0
First added on: May 15, 2024